Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Deferred Taxes (2016 - 2025)

Prestige Consumer Healthcare has reported Deferred Taxes over the past 16 years, most recently at $3.6 million for Q4 2025.

  • Quarterly results put Deferred Taxes at $3.6 million for Q4 2025, up 23.44% from a year ago — trailing twelve months through Dec 2025 was $33.9 million (up 119.58% YoY), and the annual figure for FY2025 was $14.4 million, down 37.54%.
  • Deferred Taxes for Q4 2025 was $3.6 million at Prestige Consumer Healthcare, down from $17.4 million in the prior quarter.
  • Over the last five years, Deferred Taxes for PBH hit a ceiling of $17.4 million in Q3 2025 and a floor of -$74.8 million in Q1 2023.
  • Median Deferred Taxes over the past 5 years was $4.0 million (2023), compared with a mean of $1.2 million.
  • Biggest five-year swings in Deferred Taxes: plummeted 5578.51% in 2023 and later soared 852.12% in 2025.
  • Prestige Consumer Healthcare's Deferred Taxes stood at $3.7 million in 2021, then skyrocketed by 168.25% to $9.8 million in 2022, then plummeted by 47.29% to $5.2 million in 2023, then tumbled by 43.65% to $2.9 million in 2024, then increased by 23.44% to $3.6 million in 2025.
  • The last three reported values for Deferred Taxes were $3.6 million (Q4 2025), $17.4 million (Q3 2025), and $5.8 million (Q2 2025) per Business Quant data.